THE TGA has informed that currently there are shortages of Vyvanse (lisdexamfetamine dimesilate) capsules 30mg, 50mg and 60mg which are expected to continue until Mar and Apr this year, depending on strength.
Takeda Pharmaceuticals' Vyvanse is used to treat conditions such as attention deficit hyperactivity disorder and binge eating disorder.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jan 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jan 24